SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients

PURPOSE: Patients with X-linked agammaglobulinemia (XLA) are characterized by humoral impairment and are routinely treated with intravenous immunoglobulin (IVIG). In this study, we aimed to investigate the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in IVIG pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Raphael, Allon, Shamriz, Oded, Tvito, Ariella, Magen, Sophie, Goldberg, Shmuel, Megged, Orli, Lev, Atar, Simon, Amos J., Tal, Yuval, Somech, Raz, Eisenberg, Rachel, Toker, Ori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090293/
https://www.ncbi.nlm.nih.gov/pubmed/37063907
http://dx.doi.org/10.3389/fimmu.2023.1156823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090293/
https://www.ncbi.nlm.nih.gov/pubmed/37063907
http://dx.doi.org/10.3389/fimmu.2023.1156823

Ejemplares similares